Clinical Trial Update: Cemiplimab as Maintenance Treatment for Advanced Adrenocortical Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating cemiplimab as maintenance therapy for advanced adrenocortical carcinoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)

Snippet

Sponsor: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | Conditions: Adrenal Cortical Carcinoma | Phase 2 | Status: RECRUITING